Woodstock Corp’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-17,410
Closed -$272K 176
2014
Q2
$272K Sell
17,410
-1,200
-6% -$17.6K 0.05% 149
2014
Q1
$244K Sell
18,610
-300
-2% -$4.69K 0.05% 155
2013
Q4
$304K Buy
18,910
+250
+1% +$3.98K 0.06% 142
2013
Q3
$311K Sell
18,660
-120
-0.6% -$1.77K 0.06% 140
2013
Q2
$189K Buy
+18,780
New +$197K 0.04% 159

Other funds holding OSIR

Woodstock Corp's OSIR Position: Q3 2014 in Review

Woodstock Corp sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q3 2014, closing a stake of 17,410 shares — an estimated $272K sold.

Woodstock Corp first reported a position in OSIR in Q2 2013 and held it in 5 quarters. The position peaked at $311K in Q3 2013. 67 funds tracked by Wall St. Rank hold OSIR as of Q3 2014.

  • Woodstock Corp reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Woodstock Corp sold 17,410 Osiris Therapeutics, Inc. Common Stock shares in Q3 2014, an estimated $272K.
  • Woodstock Corp first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 5 quarters.
  • Woodstock Corp's Osiris Therapeutics, Inc. Common Stock position peaked at $311K in Q3 2013.
  • 67 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q3 2014.

Based on Woodstock Corp's 13F filing for Q3 2014, filed 6 Oct 2014.